Process Development Scientists are responsible for designing and optimizing the processes used to manufacture pharmaceutical products at scale. Their work bridges the gap between laboratory research and large-scale production, ensuring that drugs can be produced efficiently, safely, and cost-effectively. These scientists focus on optimizing formulations, refining production techniques, and improving the consistency and quality of drug products. Their expertise is crucial in identifying the most efficient methods to scale up production without compromising product integrity or regulatory compliance. They also focus on improving the reproducibility of processes, ensuring that every batch produced meets the same high standards of quality and safety. In addition, process development scientists evaluate new technologies and techniques, such as continuous manufacturing and automation, to increase productivity and reduce manufacturing costs. Their work is key to reducing the time-to-market for new drugs, making therapies available to patients more quickly and efficiently.
They work closely with engineers and other technical experts to develop processes that can be replicated in large manufacturing facilities. Process development scientists also play a key role in troubleshooting production issues and ensuring that production processes remain adaptable to meet evolving industry needs and regulations. By optimizing manufacturing protocols, these scientists help streamline the drug development process, reduce production costs, and ensure timely delivery of medications to the market. Their contributions are essential in bringing innovative pharmaceutical therapies to patients worldwide.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico